cabozantinib and tetramethylpyrazine

cabozantinib has been researched along with tetramethylpyrazine* in 1 studies

Other Studies

1 other study(ies) available for cabozantinib and tetramethylpyrazine

Article	Year
Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents. Bioorganic & medicinal chemistry letters, 2021, 09-01, Volume: 47 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrazines; Structure-Activity Relationship; Triple Negative Breast Neoplasms	2021

Article

Year

Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.

Bioorganic & medicinal chemistry letters, 2021, 09-01, Volume: 47

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrazines; Structure-Activity Relationship; Triple Negative Breast Neoplasms

2021